Skip to main content
PEN logo

Penumbra, Inc.

PENNYSEHealthcareMedical Devices

$320.86Today:- (-)1Y +29.00%

As of Oct 16, 2026 close

Market cap
$12.71B
P/E (TTM)
79.15
Forward P/E
72.58
Dividend yield
-
52-week range
$221.26$362.41
Volume (live)
-
Avg. volume (3M)
362.09K

Penumbra (PEN) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Penumbra generated $238.66M of operating cash flow and spent $63.73M on capital expenditures. That left free cash flow of $174.93M, up 18.8% from $147.30M a year earlier, or 12.5% of revenue.

Penumbra Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Penumbra, Inc. (PEN) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income177.6914.0190.95-2.002.62-19.2648.462.914.66
Depreciation & Amortization17.4723.7027.2627.5716.4112.897.856.173.78
Deferred Income Tax21.03-16.34-19.061.46-14.09-18.821.82-6.48-4.29
Stock Based Compensation59.2146.1650.520.0065.7625.540.0018.4217.81
Change in Working Capital-42.72-23.78-79.08-121.54-66.71-51.19-56.84-30.26-13.49
Change in Accounts Receivable-19.5126.60-0.27-69.86-21.34-8.30-25.03-25.76-9.12
Change in Inventory-26.48-65.66-67.71-74.63-51.55-56.98-41.41-22.29-18.83
Change in Accounts Payable3.074.171.1013.39-1.57-0.316.041.331.85
Change in Other Working Capital0.2111.1120.559.57-13.0314.393.5616.4612.60
Other Operating Activities0.21124.7220.5538.84-8.5817.5925.3638.054.22
Net Cash from Operating Activities238.66168.4897.33-55.669.50-33.2426.6528.8112.69
Investing Activities
Capital Expenditures-63.73-21.18-15.21-19.30-21.18-24.76-22.11-9.60-15.03
Acquisitions0.000.00-0.990.002.920.000.80-20.41-9.25
Purchases of Investments-355.74-32.91-81.940.00-126.79-153.06-77.33-109.61-194.92
Sales/Maturities of Investments14.88130.6282.5774.09123.7276.7395.36139.24141.56
Other Investing Activities0.001.10-0.500.00-0.40-3.06-8.6429.63-55.87
Net Cash from Investing Activities-404.5977.62-16.0854.79-21.74-104.15-11.91-0.39-77.65
Financing Activities
Debt Repayment-2.49-2.28-1.98-1.75-1.45-3.42-2.57-0.40-1.08
Common Stock Issued31.8217.1720.4121.5518.37134.7613.107.23106.27
Common Stock Repurchased0.00-100.39-2.070.00-15.830.000.00-17.730.00
Other Financing Activities-2.80-1.52-2.23-8.18-0.253.58-20.29-9.41-0.83
Net Cash from Financing Activities26.53-87.0116.2011.620.84134.92-9.76-9.82104.36
Summary
Effect of Forex Changes on Cash1.89-2.180.17-0.271.11-0.64-0.05-1.40-2.00
Net Change in Cash-137.51156.9297.6310.48-10.29-3.114.9317.2137.40
Cash at Beginning of Period324.40167.4969.8659.3869.6772.7867.8550.6413.24
Cash at End of Period186.90324.40167.4969.8659.3869.6772.7867.8550.64
Free Cash Flow174.93147.3082.12-74.96-11.68-58.004.5419.21-2.34
Supplemental Disclosures
Income Taxes Paid-20.676.562.921.501.41---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Penumbra Cash Flow

What is Penumbra's free cash flow?

Penumbra generated free cash flow of $174.93M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $238.66M minus $63.73M of capital expenditures. That was up 18.8% from $147.30M a year earlier. Free cash flow equaled 12.5% of revenue.

How much does Penumbra spend on capital expenditures?

Penumbra spent $63.73M on capital expenditures in fiscal 2025, compared with $21.18M a year earlier. That equals 26.7% of operating cash flow.

Does Penumbra pay dividends or buy back shares?

Penumbra's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition